Glutaric Acidemia I

1

Review clinical trials related to Glutaric Acidemia I. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Systemic Biomarkers of Brain Injury From Hyperammonemia

Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema and vascular compromise leading to intellectual and developmental disabilities. The following aims are proposed: Aim 1 of this study will be to determine the chronology of biomarkers of brain injury in response to a hyperammonemic (HA) brain insult in patients with an inherited hyperammonemic disorder. Aim 2 will be to determine if S100B, NSE, and UCHL1 are altered in patients with two other inborn errors of metabolism, Maple Syrup Urine Disease (MSUD) and Glutaric Acidemia (GA1).

Participants needed: 24
Trial details
Age: 7-18Biological sex: AllType: ObservationalSponsor: Children's National Research InstituteUpdated: Feb 7, 2024Locations: 1
Eligibility criteria

N-acetylglutamate Synthetase Deficiency (NAGS) [+20]

Prior Solid-Organ Transplant [+1]